ghk cu tolerance desensitization downregulation antibody formation Engineered antibodies that stabilize drug-modified KRASG12C neoantigens enable selective and potent cross-HLA immunotherapy Tolerogenic nanoparticles mitigate the formation
Tolerogenic nanoparticles mitigate the formation of anti drug antibodies against pegylated uricase in patients with hyperuricemia Nature Communications The role of antibody glycosylation in autoimmune and alloimmune kidney diseases Nature Reviews Nephrology Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer's Disease Journal of Medicinal Chemistry NK Cell Degranulation Triggered by Rituximab Identifies Potential Markers of Subpopulations with Enhanced Cytotoxicity toward Malignant B Cells Frontiers Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and Target
Pay in 4 interest-free payments of $6.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




